Tibet Weixinkang Medicine Co., Ltd. (SHA:603676)

Tibet Weixinkang Medicine Revenue

Tibet Weixinkang Medicine had revenue of 322.14M CNY in the quarter ending March 31, 2026, with 8.90% growth. This brings the company's revenue in the last twelve months to 1.16B, down -9.08% year-over-year. In the year 2025, Tibet Weixinkang Medicine had annual revenue of 1.14B, down -12.65%.

• Revenue (ttm): 1.16B
• Revenue Growth: -9.08%
• P/S Ratio: 3.35
• Revenue / Employee: 1.52M
• Employees: 763
• Market Cap: 3.90B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.14B	-164.48M	-12.65%
Dec 31, 2024	1.30B	-22.41M	-1.69%
Dec 31, 2023	1.32B	-75.89M	-5.43%
Dec 31, 2022	1.40B	364.92M	35.31%
Dec 31, 2021	1.03B	317.96M	44.43%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 10, 2026

Data Sources Report a data error